Eric P. Sipos
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Genetics 7
- Glioma Diagnosis and Treatment 6
-
- Angiogenesis and VEGF in Cancer 4
- Ubiquitin and proteasome pathways 1
- Protein Degradation and Inhibitors 1
- Co-authors
- Henry Brem (12 shared papers)Richard E. Clatterbuck (1 shared paper)Allen K. Sills (2 shared papers)Jon Weingart (2 shared papers)Betty Tyler (3 shared papers)S. James Zinreich (1 shared paper)Donlin M. Long (1 shared paper)Matthew G. Ewend (1 shared paper)
- Journals
- Neurosurgery (3 papers)Journal of Neuro-Oncology (3 papers)Journal of neurosurgery (2 papers)Drug Metabolism Reviews (1 paper)Neurologic Clinics (1 paper)
- Partner nations
- United States
In The Last Decade
Eric P. Sipos
19 papers receiving 984 citations
Peers
Comparison fields: 5 of 104
- Genetics 262
- Biomaterials 171
- Neurology 108
- Cancer Research 72
- Pulmonary and Respiratory Medicine 151
Countries citing papers authored by Eric P. Sipos
This map shows the geographic impact of Eric P. Sipos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric P. Sipos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric P. Sipos more than expected).
Fields of papers citing papers by Eric P. Sipos
This network shows the impact of papers produced by Eric P. Sipos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric P. Sipos. The network helps show where Eric P. Sipos may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric P. Sipos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. | 1998 | 226 |
| 2 | Squalamine inhibits angiogenesis and solid tumor growth in vivo and perturbs embryonic vasculature. | 1998 | 143 |
| 3 | 1996 | 136 | |
| 4 | 1993 | 117 | |
| 5 | 1997 | 93 | |
| 6 | 1997 | 72 | |
| 7 | 1995 | 71 | |
| 8 | 1994 | 39 | |
| 9 | 1997 | 32 | |
| 10 | 2000 | 27 | |
| 11 | 1995 | 23 | |
| 12 | 2001 | 17 | |
| 13 | 1997 | 12 | |
| 14 | 1992 | 5 | |
| 15 | 2015 | 1 | |
| 16 | Transport of 1,3-bis(1,2-chloroethyl)-1-nitrosourea (BCNU) in the brain transport of following controlled release by a polymer | 1995 | 1 |
| 17 | [Gallbladder torsion in infants]. | 1990 | 1 |
| 18 | 1984 | 1 | |
| 19 | 1995 | 1 |
About Eric P. Sipos
Eric P. Sipos is a scholar working on Genetics, Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering and Surgery, having authored 19 papers that have together received 1.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Angiogenesis and VEGF in Cancer (4 papers), Nanoparticle-Based Drug Delivery (2 papers), Brain Metastases and Treatment (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Ubiquitin and proteasome pathways (1 paper), Protein Degradation and Inhibitors (1 paper) and Moyamoya disease diagnosis and treatment (1 paper). The work is most often cited by research in Genetics (262 citations), Biomaterials (171 citations), Neurology (108 citations), Cancer Research (72 citations) and Pulmonary and Respiratory Medicine (151 citations). Eric P. Sipos has collaborated with scholars based in United States. Frequent co-authors include Henry Brem, Richard E. Clatterbuck, Allen K. Sills, Jon Weingart, Betty Tyler, S. James Zinreich, Donlin M. Long, Matthew G. Ewend, W. Mark Saltzman and Martin Watts. Their work appears in journals such as Neurosurgery, Journal of Neuro-Oncology, Journal of neurosurgery, Drug Metabolism Reviews and Neurologic Clinics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.